Group 1 - The 138th Canton Fair has concluded its first phase, with the second phase scheduled from October 23 to 27, featuring approximately 3,600 new exhibitors aiming to expand their market presence and secure orders [1] - A company from Zhuhai showcased ultrasonic and millimeter-wave sensors for smart driving applications, attracting significant interest from international buyers, exceeding their expectations [1] - Another company from Taiyuan, which produces submersible pumps and cable accessories, received over one million USD in orders during the first phase, significantly surpassing their initial expectations [1] Group 2 - The Canton Fair has implemented a digital service upgrade, introducing a smart navigation system that allows buyers to select exhibition booths and products via an app, enhancing the overall exhibition experience [2]

Group 1 - The 138th Canton Fair has seen approximately 3,600 companies debuting, aiming to expand their market presence and secure orders [1] - A company from Zhuhai, specializing in ultrasonic and millimeter-wave sensors for smart driving applications, attracted significant interest from international buyers [1] - A company from Taiyuan, which produces submersible pumps and cables, exceeded expectations by securing over one million USD in orders during the first phase of the fair [5] Group 2 - The atmosphere at the fair was described as vibrant, with international customers expressing confidence and enthusiasm for Chinese manufacturing [1][3] - The fair has made a strong impression on first-time exhibitors regarding its service offerings, including convenient on-site support [7] - The Canton Fair has implemented a digital service upgrade, featuring a smart navigation system that enhances the visitor experience by allowing customers to easily locate desired exhibits [9][11]

Core Viewpoint - GE Healthcare is reportedly exploring options to sell its stake in the Chinese market due to declining revenues, rising tariff costs, and increasing competition from local players [2][3] Financial Performance - GE Healthcare's global revenue for the year ending December 31, 2024, was $19.7 billion, a slight increase of 1% year-on-year [2] - The revenue from the Chinese market for GE Healthcare was $2.36 billion, representing a significant decline of 15% year-on-year, marking the largest drop since the company became independent in 2023 [2] - In the first half of 2025, GE Healthcare reported a further 3% decline in revenue from the Chinese market [3] Market Comparison - In the first half of 2025, Siemens Healthineers achieved revenue of €11.571 billion (approximately $13.39 billion), a year-on-year increase of 7% [3] - GE Healthcare's revenue for the same period was $9.78 billion, reflecting a 3% year-on-year growth [3] - Philips Healthcare reported revenue of €8.174 billion (approximately $9.46 billion), showing a year-on-year decline of 1.77% [3] - Siemens Healthineers was the only major player to experience growth in the Chinese market, with a 2.4% increase, while GE Healthcare and Philips saw declines of 2% and 11%, respectively [3]

Group 1 - GE Healthcare Technologies (GEHC.US) is exploring various options, including the potential sale of its Chinese subsidiary, with valuations possibly reaching several billion dollars [1] - The company is working with advisors to assess the prospects of its business in China, although no final decisions on timing or scale have been made [1] - Other multinational companies, such as Starbucks (SBUX.US) and General Mills (GIS.US) with Häagen-Dazs, are also considering divesting their operations in China due to intense local competition [1] Group 2 - General Electric (GE) divested its medical equipment business in 2023, and GE Healthcare's stock has decreased by 2% this year, with a current valuation of approximately $35 billion [2] - GE Healthcare's product offerings include imaging scans, ultrasound, patient care solutions, and pharmaceutical imaging agents [2] - China is GE Healthcare's second-largest market, employing around 7,000 people, with projected revenues of $2.4 billion for 2024, reflecting a 15% decline from the previous year [2]